Infosys Ltd ADR Fair Value Analysis: Valuation Quality and Assump
Infosys Ltd ADR Fair Value Analysis
Infosys Ltd ADR provides digital transformation, consulting and IT services to clients worldwide. The company operates in the information technology sector and serves industries from banking to healthcare. At the current price of 12.03 USD our fair value sits at 15.23 USD, suggesting the stock trades below its estimated worth on our models. The quality score stands at 70 out of 100 and our overall verdict is undervalued.
Recent Performance and Earnings Context
Infosys delivered solid results for the first quarter ended June 30 2026. Revenue rose 14 percent year over year to 48,211 crore rupees while net profit increased 12 percent to 7,769 crore rupees. Operating margins held steady near 21 percent. Deal wins remained robust and the company appointed a new CEO designate. These figures support steady demand for its services despite a competitive landscape.
Why the Stock Appears Undervalued on Our Models
Our valuation framework incorporates multiple models that weigh growth prospects, cash flow generation and return on capital. Infosys benefits from recurring revenue streams and a diversified client base. The current price implies lower expectations than our baseline projections for earnings expansion. A quality score of 70 out of 100 reflects sound fundamentals without reaching the highest tier due to sector cyclicality.
Key valuation drivers include consistent operating margins above 20 percent, double digit revenue growth in the latest quarter and a large addressable market for digital services. These elements feed into discounted cash flow and peer comparison approaches that arrive at the 15.23 USD fair value.
Main Risks to Consider
Investors should monitor several factors. Currency movements between the rupee and dollar can affect reported results. Intense competition from other IT firms may pressure pricing. Slower client budgets during economic slowdowns represent another headwind. Geopolitical tensions and regulatory changes in key markets add further uncertainty.
Balanced Verdict
Infosys Ltd ADR combines reliable execution with attractive valuation metrics on our platform. The gap between the current price of 12.03 USD and the fair value of 15.23 USD highlights opportunity while the 70 out of 100 quality score signals a solid but not exceptional business. Risks remain typical for the sector yet recent results provide a constructive backdrop. This analysis draws on publicly available data and our proprietary models.
Check the latest figures and run your own scenarios on the free Fair Value Calculator to evaluate Infosys Ltd ADR alongside thousands of other stocks.
Visit our fair value calculator for more detailed analysis across 35,000 plus equities and 21 valuation models.
What is the fair value of Infosys Ltd ADR?
Our models estimate the fair value of Infosys Ltd ADR at 15.23 USD compared to the current market price of 12.03 USD.
Why is Infosys Ltd ADR considered undervalued?
Strong recent revenue growth, solid margins and our valuation models point to the stock trading below its estimated fair value with a quality score of 70 out of 100.
What are the main risks for Infosys Ltd ADR investors?
Key risks include currency fluctuations, competition in IT services and slower client spending amid economic uncertainty.
Sources
Context gathered via live web search while writing this article:
- https://blog.rangvid.com/2026/01/11/the-bear-case-for-stocks-in-2026/
- https://www.macroaxis.com/invest/advice/INFY
- https://economictimes.indiatimes.com/markets/infosys-q1-results
- https://www.infosys.com/investors/reports-filings/quarterly-results.html
- https://www.financecharts.com/stocks/INFY/bulls-bears
- https://finance.yahoo.com/news/infosys-limited-infy-bull-case-215819311.html
- https://realinvestmentadvice.com/resources/blog/the-bullish-and-bearish-case-for-2026/
- https://www.infosys.com/investors/reports-filings/quarterly-results/2026-2027/q1.html
Not financial advice and not a buy or sell recommendation. Valuations are model-based and may be wrong; past performance does not indicate future results.
21 valuation models · 35,000+ stocks · evidence-based
Start free →